MACKENZIE FINANCIAL CORP
Position in NBIX — Neurocrine Biosciences Inc
CIK 919859
TORONTO ONTARIO, A6
Position in NBIX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12,077,527
+$1,179,310 QoQ
Shares Held
91,677
+19.3% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MACKENZIE FINANCIAL CORP holds $105,409,906 across 15 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
714,561 | $54,199,451 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
91,677 | $12,077,527 | |
| 3 | ALKS |
Alkermes plc.
|
249,182 | $8,811,075 | |
| 4 | VTRS |
Viatris Inc
|
534,364 | $7,219,257 | |
| 5 | ZTS |
Zoetis Inc.
|
54,702 | $6,466,323 | |
| 6 | PAHC |
Phibro Animal Health Corp
|
75,044 | $4,150,683 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
4,679 | $2,774,553 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
243,416 | $2,317,320 |
All Filings in NBIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,077,527 | 91,677 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $10,898,217 | 76,840 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $11,914,612 | 84,874 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,516,869 | 75,717 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,523,655 | 86,109 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $7,537,666 | 55,221 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $9,976,093 | 86,583 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,228,813 | 88,827 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,662,435 | 91,810 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $12,761,614 | 96,855 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $10,758,487 | 95,631 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $8,708,982 | 92,354 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,888,723 | 48,298 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $4,714,177 | 39,469 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,766,525 | 35,463 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $4,204,897 | 43,136 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,802,750 | 29,896 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $868,137 | 10,193 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,412,370 | 14,726 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $944,879 | 9,709 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $957,426 | 9,845 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,645,073 | 17,163 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,574,908 | 16,378 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,016,748 | 8,334 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||